Analyst firms · UBS · INSP
UBS INSP price target and rating history
Inspire Medical Systems Inc. (INSP) · Health Care
UBS rates Inspire Medical Systems Inc. (INSP) Sell with a $39 price target, as of its latest action on Jul 28, 2026. It has published 3 rating actions on INSP since March 2023, including 0 upgrades and 1 downgrade. Across 12 firms with a INSP price target in the last 12 months, the median target is $72. UBS's $39 is 46% below that.
- Current rating
- Sell
- Price target
- $39
- Median target, all firms
- $72
- Actions on INSP
- 3
UBS price target on INSP
Every UBS rating on INSP
- Jul 28, 2026
- Sep 22, 2025
- Mar 29, 2023
How other firms rate INSP
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Barclays | Underweight | $65 | Oct 7, 2026 |
| Oppenheimer | Outperform | $85 | Aug 4, 2026 |
| UBS | Sell | $39 | Jul 28, 2026 |
| Evercore ISI | In-line | $40 | Jun 23, 2026 |
| BofA Securities | Underperform | $39 | May 22, 2026 |
| Piper Sandler | Neutral | $55 | May 5, 2026 |
| Wolfe Research | Peer Perform | $180 | Feb 13, 2026 |
| Robert W. Baird | Neutral | $74 | Feb 12, 2026 |
| Wells Fargo | Equal Weight | $70 | Feb 12, 2026 |
| RBC Capital Markets | Sector Perform | $90 | Jan 27, 2026 |
| Truist Securities | Hold | $96 | Jan 22, 2026 |
| Morgan Stanley | Equal-Weight | $130 | Dec 2, 2025 |
| Stifel | Buy | Nov 24, 2025 |
Questions about UBS and INSP
- What is UBS's price target for INSP?
- UBS's latest stated price target for Inspire Medical Systems Inc. (INSP) is $39, from its action on Jul 28, 2026.
- What is UBS's rating on INSP?
- UBS rates INSP Sell, a bearish rating, as of Jul 28, 2026.
- When did UBS last change its view on INSP?
- On Jul 28, 2026, UBS resumes coverage at Sell, price target $39.
- How does UBS's INSP target compare with other analysts?
- Across 12 firms with a INSP price target in the last 12 months, the median target is $72. UBS's $39 is 46% below that.
More INSP rating histories
- Oppenheimer3
- BofA Securities5
- Piper Sandler5
- Wolfe Research3
- Wells Fargo4
- Truist Securities4
- KeyBanc Capital Markets3
- Leerink Partners4
All UBS ratingsINSP news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.